Navigation Links
A New, Unique and Unrivalled Rat/Mouse PINP Assay for Pharmaceutical, Clinical and Academic Research Organizations.
Date:1/14/2008

BOLDON, England, January 14 /PRNewswire/ -- IDS is pleased to announce that their new, unique immunoassay Rat/Mouse PINP- the first commercial EIA to allow the specific assessment of type I collagen levels in rodent specimens*, is now available.

The IDS Rat/Mouse P1NP is the first commercial EIA to allow the specific assessment of type I collagen levels in rodent specimens*. The use of this assay will aid the assessment of new osteoporosis drug candidates in pre-clinical studies and is therefore ideal for Pharmaceutical, Clinical and Academic Research Organizations alike.

The IDS Rat/Mouse PINP EIA is very flexible and measures PINP released from collagen synthesis in rats or mice (plasma or serum). The cross-reactivity with human-derived P1NP is not detectable.

The assay is very simple to perform and results are available in under 3 hours. The assay format and quality also allows one operator to perform over 160 tests per day ensuring high sample throughput and precise, sensitive results.

The combination of 8 well microtiter strips and up to 12 months shelf life also makes this kit ideal for academic researchers with low sample throughput providing quicker and more cost-effective results.

The IDS PINP EIA further expands the range what we believe to be the largest range of Bone & Cartilage Immunoassays available globally.

* Additional Information

The generation of type I collagen is a crucial step in bone formation where type I collagen is the major organic component of bone matrix. Propeptides are cleaved from both the N- and C-terminal ends of the procollagen molecule in equimolar concentrations during collagen synthesis. Thus, the quantification of N-terminal propeptide of type I procollagen (PINP) provides measurement of collagen synthesis and/or bone formation.

Contact:

Dean Hutchinson

Head of Marketing,

IDS LTD.

Telephone: +44(0)191-519-6104

Fax: +44(0)191-519
'/>"/>

SOURCE IDS Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. American M.R.I.-DOL: Small Hospitals To Turn The Camera On Themselves In Unique National Contest
2. Study Reaffirms Superiority of Trofile(TM) Assay
3. EpiCept to Present Pre-clinical Advances of Myc Oncogene Directed Drug Discovery at Assays and Cellular Targets Conference
4. Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use for HemosIL(R) D-Dimer HS Assay
5. MedAssets Supply Chain Systems Selects Siemens Medical Solutions Diagnostics for Chemistry, Automation and Immunoassay Solutions
6. Assay Designs(TM) Announces Additions to the Leadership Team
7. ProImmune Launches New MHC-Peptide Binding Assay for Class II HLA Alleles
8. Caliper Life Sciences Introduces High Throughput RNA Assay to Improve Workflow in Gene Expression Studies
9. Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products
10. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
11. Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... Washington, USA (PRWEB) September 30, 2014 ... yet efficient arrangements that have evolved in nature over ... biomimetic and bioinspired materials for applications in biophotonics ... Biomedical Optics . The journal is published by SPIE, ... SPIE Digital Library. Several of the peer-reviewed articles are ...
(Date:10/1/2014)... 30, 2014 This report analyzes ... US$ Million by the following Product Segments: ... Specific end-use segments also analyzed are Pharmaceuticals ... The report provides separate comprehensive analytics for ... East, and Latin America. Annual estimates and ...
(Date:9/30/2014)... bio-mimicking analog of one of nature,s most efficient ... team led by Alejandro Briseno of the University ... in developing long-sought polymer architecture to boost power-conversion ... electronic devices. , Briseno, with colleagues and ... Stanford University and Dresden University of Technology, Germany, ...
(Date:9/30/2014)... 30, 2014 Over the last decade, ... to rising R&D budgets and increased acceptance of new ... pharmaceutical and biotechnology industries are also catalyzing the growth ... market is expected to grow at a strong CAGR ... to be worth $2,532.6 million by 2019. The market ...
Breaking Biology Technology:Biomimetic and bioinspired materials enable new healthcare options, reports Journal of Biomedical Optics 2Biomimetic and bioinspired materials enable new healthcare options, reports Journal of Biomedical Optics 3Global Specialty Enzymes Industry 2Global Specialty Enzymes Industry 3Global Specialty Enzymes Industry 4Global Specialty Enzymes Industry 5Global Specialty Enzymes Industry 6Global Specialty Enzymes Industry 7Global Specialty Enzymes Industry 8Global Specialty Enzymes Industry 9Global Specialty Enzymes Industry 10Global Specialty Enzymes Industry 11Global Specialty Enzymes Industry 12Global Specialty Enzymes Industry 13Global Specialty Enzymes Industry 14Global Specialty Enzymes Industry 15Global Specialty Enzymes Industry 16Global Specialty Enzymes Industry 17Global Specialty Enzymes Industry 18Global Specialty Enzymes Industry 19Global Specialty Enzymes Industry 20Global Specialty Enzymes Industry 21Global Specialty Enzymes Industry 22Global Specialty Enzymes Industry 23Global Specialty Enzymes Industry 24Global Specialty Enzymes Industry 25Global Specialty Enzymes Industry 26Blades of grass inspire advance in organic solar cells 2Blades of grass inspire advance in organic solar cells 3Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 2Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 3Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 4Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 5
... CITY, China , May 11 /PRNewswire-Asia-FirstCall/ -- China Pharma,Holdings, ... leading,fully-integrated specialty pharmaceuticals company in China , today announced,financial results for ... First Quarter Highlights, -- Revenue increased 16% ... quarter of fiscal 2009, -- Gross ...
... of Gothenburg, Sweden, have managed, with the help of an ... photosynthesis an achievement that has been recognised by the ... Facility in Grenoble is home to one of the world,s ... by researchers to photograph and study life,s tiniest components: atoms, ...
... , May 10 BioMed Realty Trust, Inc. (NYSE: ... be held on Tuesday, May 11, 2010 at BioMed,s The Landmark ... feature presentations by Alan D. Gold , Chairman and Chief Executive Officer, ... , , ...
Cached Biology Technology:China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 2China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 3China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 4China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 5China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 6China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 7China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 8China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 9China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 10China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 11BioMed Realty Trust to Webcast Company Presentation at Investor Day 2010 2
(Date:9/30/2014)... as something that we enjoy when we visit a national ... think of ourselves as a part of nature? A bird,s ... house? , The answers to these questions reflect different ... speech and in cultural artifacts. , A new Northwestern University ... Indian Center of Chicago and the Menominee tribe of Wisconsin, ...
(Date:9/30/2014)... The National Institutes of Health (NIH) awarded ... to develop an electrode array system that will ... works through unprecedented resolution and scale. , LLNL,s ... support President Obama,s BRAIN (Brain Research through ... effort to revolutionize our understanding of the human ...
(Date:9/30/2014)... Journal of Medicine reports positive results of a ... the subset of lung cancer marked by rearrangement of ... patients with advanced non-small cell lung cancer testing positive ... percent, with 3 complete responses and 33 partial responses. ... the disease to resume its growth after being slowed ...
Breaking Biology News(10 mins):The cultural side of science communication 2NIH taps lab to develop sophisticated electrode array system to monitor brain act 2NIH taps lab to develop sophisticated electrode array system to monitor brain act 3NEJM: Crizotinib effective in Phase 1 trial against ROS1 lung cancer 2
... changes in the earth,s atmospheric composition are likely to ... dioxide will reach levels double those of the preindustrial ... produce enough food for a rapidly growing population. ... of elevated carbon dioxide, elevated ozone and higher atmospheric ...
... This release is available in German . ... so far considered antagonists, also work synergistically. The activities of ... formation of organs, such as leaves and buds, are in ... Tbingen (Germany) and Umea (Sweden) made this surprising discovery in ...
... AUGUSTA, Ga. - The most common and under-diagnosed ... the worst form of macular degeneration, Medical College of Georgia ... which results in iron overload, and the wet form of ... and older. They suspect that too much iron, known to ...
Cached Biology News:Climate change complicates plant diseases of the future 2Climate change complicates plant diseases of the future 3Plant growth hormones: Antagonists cooperate 2Link between iron overload and macular degeneration under study 2Link between iron overload and macular degeneration under study 3